Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis.
about
Automated identification of abnormal metaphase chromosome cells for the detection of chronic myeloid leukemia using microscopic images.Cytokine signalling and disease.The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinibChronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.Loss of Bcl-x in Ph+ B-ALL increases cellular proliferation and does not inhibit leukemogenesisComparison of microRNA expression profiles in K562-cells-derived microvesicles and parental cells, and analysis of their roles in leukemia.Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?Pharmacological activation of wild-type p53 in the therapy of leukemia.L-amino acid oxidase isolated from Bothrops pirajai induces apoptosis in BCR-ABL-positive cells and potentiates imatinib mesylate effect.Increased acetylation of lysine 317/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage.PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cellsArsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cdelta.Flow cytometric detection of total and serine 473 phosphorylated Akt.Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia.Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib.Evaluation of the potential synergism of imatinib-related poly kinase inhibitors using growth factor stimulated proteoglycan synthesis as a model response.Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells.
P2860
Q34088292-A9E5639D-BE0D-4B03-BE0A-4E72D3170460Q35050409-5DE9E907-315B-46B1-9A24-C9CA1EB4D5BCQ35377275-E9F4FD3B-86A2-4325-BA34-BCFD9D0AA65AQ35640320-427D4064-719F-44AF-98E9-3B1542E4560EQ36508955-7A2B1BF4-6483-4B3D-B73B-AF44276AA0C1Q37582348-518F5C51-157E-45C5-983B-53A4F4331BC7Q38144200-D500FEF9-8275-4F4F-8F48-A55EF95805CFQ38872029-38B20B3F-2D27-4D5A-9E3B-909F9BCF8EF3Q39172206-3E524490-E286-48E3-A9A8-E7CEAF8DED42Q39331696-EDE08EE9-C2C3-42AD-9405-5C7C10F00A21Q39919462-7CEFD526-6E16-4284-AE25-8D24DA2CF0C1Q40134056-6A2BF365-A3D7-4BBD-8D03-AEEA1C42EA94Q40636307-3CC71D3B-BEDC-40C3-A505-FF3F1936E456Q42330162-4013B23B-200F-4FA2-AD35-93CB91D26BF6Q45991055-389C3E48-6359-4476-A708-CE9F1C0BA75DQ54214231-8DC48169-AF6B-4666-B0BA-3565166F80FBQ54364714-8A357193-2B9A-4239-9403-55809EEE3FD7
P2860
Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@ast
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@en
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@nl
type
label
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@ast
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@en
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@nl
prefLabel
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@ast
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@en
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@nl
P2093
P921
P1433
P1476
Molecular abnormalities in chr ...... of cell growth and apoptosis.
@en
P2093
P304
P356
10.1634/THEONCOLOGIST.5-5-405
P577
2000-01-01T00:00:00Z